Jobs’ death likely a complication of rare cancer

APPLE founder Steve Jobs managed to live more than seven years with a rare form of pancreatic cancer that grows more slowly than the common kind.

But his need for a liver transplant two years ago was a bad sign that his troubles with the disease probably were not over.

Mr Jobs long kept information on his illness behind a firewall, and no new details emerged immediately after his death yesterday at the age of 56.

However, medical experts not connected with his care say he most likely needed the transplant because of cancer recurrence or metastasis.

They said his death could have been from cancer, the new liver not working, or complications from immune-suppressant medication.

A liver transplant can cure the type of cancer Mr Jobs had, but "if it were to come back, it's usually in 1–2 years," said Dr Michael Pishvaian, a US gastrointestinal cancer specialist at Georgetown University's Lombardi Comprehensive Cancer